Analysts’ ratings for BioNTech shares at a glance.
2 experts published their stock analysis of BioNTech (ADRs) last month.
2 experts rate the BioNTech (ADRs) share as a buy.
On average, analysts forecast a price target of $153.00 for BioNTech (ADRs) shares, an increase of $57.96 from the current NAS price of $95.04.
The 6-month rating trend indicates Buy.
| Analyst | Price target | Distance price target | Date | |
|---|---|---|---|---|
| Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | $155.00 | 63.09 | 12/11/2025 | |
| Jefferies & Company Inc. | $151.00 | 58.88 | 12/03/2025 |
Editorial team finanzen.net
By the way: BioNTech (ADRs) and other US stocks can even be traded on finanzen.net ZERO until 11 p.m. (without order fees, plus spreads). Open a depot now for free and secure a new customer bonus!
Selected leverage products on BioNTech (ADRs)
With knock-outs, speculative investors can participate disproportionately in price movements. Simply select the desired leverage and we will show you suitable open-end products on BioNTech (ADRs)
The leverage must be between 2 and 20
Advertising